Literature DB >> 22641362

Clinical trials: New options for melanoma?

Rebecca Kirk.   

Abstract

Entities:  

Year:  2012        PMID： 22641362     DOI： 10.1038/nrclinonc.2012.95

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.

Authors:  Gerald S Falchook; Georgina V Long; Razelle Kurzrock; Kevin B Kim; Tobias H Arkenau; Michael P Brown; Omid Hamid; Jeffrey R Infante; Michael Millward; Anna C Pavlick; Steven J O'Day; Samuel C Blackman; C Martin Curtis; Peter Lebowitz; Bo Ma; Daniele Ouellet; Richard F Kefford
Journal:  Lancet       Date:  2012-05-19       Impact factor: 79.321
  1 in total
  1 in total

1.  Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.

Authors:  Joshua Bakhsheshian; Bih-Rong Wei; Ki-Eun Chang; Suneet Shukla; Suresh V Ambudkar; R Mark Simpson; Michael M Gottesman; Matthew D Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.